John Kenneth Jenkins Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading activity

John Kenneth Jenkins is of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 33 shares of CRBP, which is worth approximately $248. The most recent transaction as insider was on May 30, 2025, when has been sold 2,783 shares (Common Stock, par value $0.0001 per share) at a price of $7.35 per share, resulting in proceeds of $20,455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33

98.83% 3M change

98.83% 12M change

Total Value Held $248

John Kenneth Jenkins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2025	SELL Open market or private sale	$20,455 $7.35 p/Share	2,783 Reduced 98.83%	33 Common Stock, par valu...
May 30 2025	BUY Grant, award, or other acquisition	-	4,800 Added 49.83%	4,833 Common Stock, par valu...
May 30 2024	BUY Grant, award, or other acquisition	-	2,783 Added 49.71%	2,816 Common Stock, par valu...

Also insider at

PRVB

Provention Bio, Inc. Healthcare

Director

JKJ